Clinical experience shows that there is a therapeutic window between 60 and
70 Gy where many tumours are eradicated, but the function of the adjacent
normal tissues is preserved. This implies much more cell kill in the: tumou
r than is acceptable in the normal tissue. An SF2 of 0.5 or lower is needed
to account for the eradication of all tumour cells. while an SF2 of 0.8 or
higher is needed to explain why these doses are tolerated by normal tissue
s. No such systematic difference is known between the intrinsic sensitivity
of well-oxygenated normal and tumour cells. The presence of radioresistant
hypoxic cells in rumours makes it even more difficult ro understand the cl
inical success. However, there is experimental evidence that starved cells
lose their repair competence as a result of the depletion of cellular energ
y char gr. MRS studies have shown that low ATP levels are a characteristic
feature of solid tumours in rodents and man. In this paper we incorporate t
he concept of repair incompetence in starving, chronically hypoxic cells. T
he increased sensitivity of such cells has been derived From an analysis of
mammalian cell lines showing inducible repair. It is proportional to the S
F2 and highest in resistant cells. Thr distinction between acutely hypoxic
radioresistant cells and chronically hypoxic radiosensitive cells provides
the key to the realistic modelling of successful radiotherapy. It also open
s new conceptual approaches to radiotherapy. We conclude that it is essenti
al to distinguish between these two kinds of hypoxic cells in predictive as
says and models.